Goldman Sachs Shops Near $4 Billion Deal for DuPont Unit (1)

Goldman Sachs Group Inc. is leading a $3.75 billion debt deal to fund Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business, according to people familiar with the matter.

The lender is weighing investor interest for a deal comprising a $3 billion term loan and a $250 million delayed-draw term loan, said the people familiar with the transaction, who requested anonymity to discuss a private transaction. The financing will also include a $500 million revolving credit facility, said one of the people.

Some of the proceeds from the debt raise will support Arclin’s roughly $1.8 billion acquisition ...